Metis Global Partners LLC Raises Position in Synopsys, Inc. $SNPS

Metis Global Partners LLC grew its stake in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 15.5% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,894 shares of the semiconductor company’s stock after purchasing an additional 1,329 shares during the quarter. Metis Global Partners LLC’s holdings in Synopsys were worth $4,882,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. Stanley Laman Group Ltd. boosted its holdings in Synopsys by 542.9% in the 3rd quarter. Stanley Laman Group Ltd. now owns 12,877 shares of the semiconductor company’s stock valued at $6,353,000 after purchasing an additional 10,874 shares during the period. Symphony Financial Ltd. Co. raised its position in shares of Synopsys by 4,780.9% in the second quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock worth $20,638,000 after buying an additional 39,395 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in Synopsys by 0.4% during the second quarter. Bank of New York Mellon Corp now owns 1,347,887 shares of the semiconductor company’s stock valued at $691,035,000 after buying an additional 4,815 shares during the period. Waverton Investment Management Ltd boosted its stake in Synopsys by 15.0% during the second quarter. Waverton Investment Management Ltd now owns 578,299 shares of the semiconductor company’s stock valued at $296,630,000 after buying an additional 75,374 shares during the period. Finally, Angeles Wealth Management LLC purchased a new position in Synopsys during the second quarter worth about $478,000. Institutional investors own 85.47% of the company’s stock.

Synopsys Stock Up 3.2%

Shares of SNPS opened at $437.09 on Friday. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52. The stock has a 50 day simple moving average of $477.13 and a two-hundred day simple moving average of $490.76. The firm has a market cap of $83.62 billion, a P/E ratio of 54.70, a P/E/G ratio of 3.53 and a beta of 1.12.

Synopsys (NASDAQ:SNPSGet Free Report) last posted its quarterly earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, topping the consensus estimate of $2.79 by $0.11. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The business’s revenue was up 37.8% compared to the same quarter last year. During the same period last year, the firm posted $3.40 earnings per share. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, analysts forecast that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. Citigroup initiated coverage on Synopsys in a report on Monday, November 24th. They issued a “buy” rating and a $580.00 price target on the stock. Piper Sandler cut shares of Synopsys from an “overweight” rating to a “neutral” rating and decreased their price objective for the stock from $602.00 to $520.00 in a research report on Tuesday, January 13th. Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and lowered their target price for the company from $525.00 to $500.00 in a research note on Monday, December 8th. KeyCorp boosted their price target on shares of Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a research note on Thursday, December 11th. Finally, Needham & Company LLC increased their price target on shares of Synopsys from $550.00 to $580.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. Nine equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Synopsys presently has an average rating of “Moderate Buy” and a consensus price target of $553.57.

Read Our Latest Research Report on Synopsys

Insiders Place Their Bets

In other news, insider Janet Lee sold 250 shares of Synopsys stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the transaction, the insider owned 11,959 shares in the company, valued at approximately $6,338,270. The trade was a 2.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the sale, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 4,157 shares of company stock worth $1,945,036. 0.62% of the stock is owned by corporate insiders.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Recommended Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.